Found 0 matching trials
Adaptive Mobile Interventions to Reduce Cancer Risk Behaviors
NATobacco use remains the leading cause of preventable death, causing over 40...
Location
Johns Hopkins Bloomberg School of Public Health
Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14
PHASE3Summary
In patients with prostate cancer (PC) who have only biochemically ...
Location
Copenhagen University hospital, Rigshospitalet
AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia
PHASE1This phase I trial studies the side effects and best dose of AR-42 when giv...
Location
Cincinnati Children's Hospital
Treatment of Erectile Dysfunction - Long Term Safety and Efficacy
PHASE3Open-Label Phase 3 study to evaluate the long-term safety and efficacy of u...
Location
Warner Chilcott Investigational Site
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
PHASE2This study will address the question of whether targeting CMV antigens with...
Location
Children's Hospital Colorado
Extracorporeal Photopheresis in Sezary Syndrome
N/AThe primary endpoint is to determine if ECP induces a decrease in % of tumo...
Location
Emory University School of Medicine
Efficacy, Safety and Tolerability of AG013 in Oral Mucositis Compared to Placebo When Administered Three Times Per Day
PHASE2The purpose of the study is to evaluate the efficacy, safety and tolerabili...
Location
University of Connecticut Health Center
TASO-001 in Combination With Recombinant Interleukin-2(Aldesleukin) in Advanced or Metastatic Solid Tumor
PHASE1To evaluate safety, tolerance and efficacy of TASO(TGF-β2 targeting anti-se...
Location
Seoul National University Hospital
A Safety And Immunogenicity Study Of A 13-valent Pneumococcal Conjugate Vaccine In Japanese Subjects Aged 6 To 64 Years.
PHASE3This study is to evaluate the safety, tolerability and immunogenicity of a ...
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
PHASE2Researchers conducting this study hope to learn about the safety and effect...
Location
University of Chicago Comprehensive Cancer Center